Unless cures are found, Alzheimer's dementia is projected to affect nearly 13 million Americans by 2050—overwhelming families, caregivers and our healthcare system. Yet only one new therapeutic, aducanumab, has come to ...
Aug 17, 2022
0
20
An advisory panel to the U.S. Food and Drug Administration will meet Wednesday to discuss the best way forward with coronavirus vaccines, as evidence grows that variants are eroding the power of the country's current shots.
Apr 6, 2022
0
14
US experts urged regulators Wednesday to approve a second new anti-cholesterol drug, a day after recommending they bring to market the first in a new class of medications to lower the risk of heart attack.
Jun 10, 2015
0
11
Germany's independent vaccination advisory panel is recommending a booster shot with a messenger RNA vaccine for people who have had a full course of four Chinese, Indian and Russian COVID-19 vaccines that aren't currently ...
Mar 31, 2022
0
1
The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS.
May 11, 2012
0
0
(AP) -- A government panel favors expanding an aid program for people sickened by World Trade Center dust to include people who have at least some types of cancer.
Feb 16, 2012
0
0
U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week.
Jun 17, 2022
0
1
Other mental illness diagnoses, taking psychotropic medication prescribed to treat those illnesses, and specific health service use patterns are strong indicators of bipolar disorder, show researchers from the University ...
Oct 16, 2023
0
2
(HealthDay) -- A U.S. Food and Drug Administration advisory panel on Monday will weigh the wisdom of allowing new clinical trials of a class of powerful painkillers for osteoarthritis. The drugs may have worked so well for ...
Mar 12, 2012
0
0
Despite near unanimous objection from its advisory panel, the U.S. Food and Drug Administration (FDA) granted aducanumab approval to treat Alzheimer's disease on June 7, 2021. In a commentary published in Annals of Internal ...
Jun 18, 2021
0
1
